FMC
33
-3
GIS
47
4
CNX
69
14
CSX
57
3
NTRS
47
2
CHD
58
2
STX
56
-3
L
58
2
IP
44
2
AMG
38
2
DLTR
30
3
EXR
50
-14
FDX
47
3
PRGO
50
4
EW
29
7
HOG
39
3
BXP
67
2
ECL
74
2
AA
43
6
UNH
56
-3
FMC
33
-3
GIS
47
4
CNX
69
14
CSX
57
3
NTRS
47
2
CHD
58
2
STX
56
-3
L
58
2
IP
44
2
AMG
38
2
DLTR
30
3
EXR
50
-14
FDX
47
3
PRGO
50
4
EW
29
7
HOG
39
3
BXP
67
2
ECL
74
2
AA
43
6
UNH
56
-3
Financhill
Back

Columbia Research Enhanced Value ETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Buy
60

REVS
Columbia Research Enhanced Value ETF

Last Price:
24.93
Seasonality Move:
4.3%
Buy
57

RYTM
Rhythm Pharmaceuticals

Last Price:
53.08
Seasonality Move:
11.04%
Buy
60
Columbia Research Enhanced Value ETF (REVS) is a Buy

Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Value ETF [REVS] share price is $24.91. The Score for REVS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • REVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $49.52. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

REVS Stock Price Chart

What is Columbia Research Enhanced Value ETF's stock price today?

  • The Columbia Research Enhanced Value ETF share price today is $24.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $49.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

REVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 60.71 Buy
Chaikin Money Flow: 2140 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.18 - 24.92) Buy
Bollinger Bands (100): (23.13 - 24.37) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.91 Buy
Relative Strength Index (14 RSI): 57.18 Buy
Chaikin Money Flow: -131805 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.52 - 49.1) Buy
Bollinger Bands (100): (39.32 - 48.12) Buy

REVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.57 Buy
20-day SMA: 24.69 Buy
50-day SMA: 24.22 Buy
200-day SMA: 23.03 Buy
8-day EMA: 24.66 Buy
20-day EMA: 24.57 Buy
50-day EMA: 24.25 Buy
200-day EMA: 23.11 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.38 Buy
20-day SMA: 47.68 Buy
50-day SMA: 47.5 Buy
200-day SMA: 43.19 Buy
8-day EMA: 49.08 Buy
20-day EMA: 48.09 Buy
50-day EMA: 46.65 Buy
200-day EMA: 41.27 Buy

Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.

Columbia Research Enhanced Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):